Mesenchymal Stromal Cells in Osteoarthritis: Evidence for Structural Benefit and Cartilage Repair
Osteoarthritis (OA) presents a major clinical challenge to rheumatologists and orthopedists due to the lack of available drugs reducing structural degradation. Mesenchymal stromal cells (MSCs) may represent new therapeutic approaches in cartilage regeneration. In this review, we highlight the latest...
Main Authors: | Yujie Song, Christian Jorgensen |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-05-01
|
Series: | Biomedicines |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9059/10/6/1278 |
Similar Items
-
Mesenchymal Stem Cell Mechanisms of Action and Clinical Effects in Osteoarthritis: A Narrative Review
by: Vilim Molnar, et al.
Published: (2022-05-01) -
Is Culture Expansion Necessary in Autologous Mesenchymal Stromal Cell Therapy to Obtain Superior Results in the Management of Knee Osteoarthritis?—Meta-Analysis of Randomized Controlled Trials
by: Sathish Muthu, et al.
Published: (2021-12-01) -
Epigenetic Classification of Human Mesenchymal Stromal Cells
by: Danilo Candido de Almeida, et al.
Published: (2016-02-01) -
Mesenchymal stromal cell-based therapy for cartilage regeneration in knee osteoarthritis
by: Xiao-Na Xiang, et al.
Published: (2022-01-01) -
Comparing the immunomodulatory properties of bone marrow, adipose tissue and birth-associated tissue mesenchymal stromal cells
by: Philipp eMattar, et al.
Published: (2015-11-01)